Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2–16 Years in Asia and Latin America

Background. Asymptomatic dengue virus–infected individuals are thought to play a major role in dengue virus transmission. The efficacy of the recently approved quadrivalent CYD-TDV dengue vaccine against asymptomatic dengue virus infection has not been previously assessed. Methods. We pooled data fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivera-Botello, Gustavo, Coudeville, Laurent, Fanouillere, Karen, Guy, Bruno, Chambonneau, Laurent, Noriega, Fernando, Jackson, Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021228/
https://www.ncbi.nlm.nih.gov/pubmed/27418050
http://dx.doi.org/10.1093/infdis/jiw297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021228/
https://www.ncbi.nlm.nih.gov/pubmed/27418050
http://dx.doi.org/10.1093/infdis/jiw297

Ejemplares similares